GHK-Cu · For skin aging

GHK-Cu for skin aging

Fine lines, sagging, dull skin. Does GHK-Cu actually work topically?

A-Tier Skin & Recovery Strong clinical

New to peptides? Start with the foundations ->

Why people use GHK-Cu for skin aging

Fine lines, sagging, dull skin. Does GHK-Cu actually work topically? The short answer: yes, this is one of the more-discussed uses for GHK-Cu - but the evidence quality and the right protocol depend on what you're actually trying to fix.

This page covers what's known, what's not, and what the editorial take is for normal humans considering GHK-Cu for skin aging.

What the evidence says

Evidence tier: Strong clinical. Multiple human studies support the dosing protocol; not yet FDA-labeled for this exact indication but close.

GHK-Cu is a copper-binding tripeptide (three amino acids: Glycine-Histidine-Lysine bound to copper) your body makes naturally - levels drop sharply after age 60.
Topical creams at 0.1 to 2 percent concentration showed measurable wrinkle reduction and skin density gains in published clinical work (Pickart et al., 2015).
This is the strongest peptide-for-skin evidence base by a wide margin.

Protocol notes

Topical cream or serum, applied morning and night to clean skin. Most users see results at 8-12 weeks.

Always with a sports-medicine doctor, telehealth provider, or specialist sign-off. Self-experimenting on injection schedules without clinical input is the most common way people waste money and get hurt.

How it's dosed (quick version)

Topical use is the main game: a 0.1 to 2 percent cream or serum, applied to clean skin morning and night, for at least 8 to 12 weeks. Injectable GHK-Cu is biohacker territory with no real research behind it. Always with a doctor or dermatologist if injectable.

Typical starting dose: Topical 0.1 percent serum once daily for the first 2 weeks, scaling up to twice daily. Injectable: 1 mg subQ (under-the-skin shot) every other day if a clinician approves.
Typical maintenance dose: Topical 1 to 2 percent cream or serum, twice daily. Injectable users typically run 1-2 mg every other day for 4-6 weeks.
Frequency: Topical: twice daily. Injectable (off-label): every other day or 3x weekly.
Cycle length: Topical: indefinite, like any skincare ingredient. Injectable: 4-6 weeks per cycle is standard.

Full dosing breakdown ->

What to skip

Vendors without a Certificate of Analysis (COA). Random gym-bro vendors with no third-party testing. The peptide market has a quality-control problem; the answer is COA per peptide, every time.
Pre-mixed blends from non-pharmacy sources. Compounding pharmacies that produce pre-mixed combinations with COAs are fine. Random vendor "stack vials" are not.
Massively over-dosed protocols. More is rarely better with peptides. Receptor saturation is real. Stick to evidence-based dosing.

Where to go next

Full GHK-Cu directory entry - status, sourcing, studies, what to skip
What are peptides - if you skipped the foundation
How peptides actually work - mechanism in plain English
The Tier List - which ones to take seriously
Subscribe to the dispatch

Subscribe to the dispatch

The weekly Protocol One dispatch covers what's moving in peptides, GLP-1s, and longevity protocols. Free. 5-min read. Broken down for normal humans.

-> Subscribe free

Last reviewed · 2026-05-07 · Page generated by Protocol One matrix engine